MBX Biosciences Inc
NASDAQ:MBX
Intrinsic Value
The intrinsic value of one MBX stock under the Base Case scenario is 7.84 USD. Compared to the current market price of 12.47 USD, MBX Biosciences Inc is Overvalued by 37%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
MBX Biosciences Inc
Loading...
Fundamental Analysis

Revenue & Expenses Breakdown
MBX Biosciences Inc
Balance Sheet Decomposition
MBX Biosciences Inc
Current Assets | 244.3m |
Cash & Short-Term Investments | 240.8m |
Receivables | 1.4m |
Other Current Assets | 2.1m |
Non-Current Assets | 1.7m |
PP&E | 1.6m |
Other Non-Current Assets | 50k |
Free Cash Flow Analysis
MBX Biosciences Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
MBX Biosciences Inc
Revenue
|
0
USD
|
Operating Expenses
|
-81.4m
USD
|
Operating Income
|
-81.4m
USD
|
Other Expenses
|
7.9m
USD
|
Net Income
|
-73.5m
USD
|
MBX Profitability Score
Profitability Due Diligence
MBX Biosciences Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
Score
MBX Biosciences Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
MBX Solvency Score
Solvency Due Diligence
MBX Biosciences Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
MBX Biosciences Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MBX Price Targets Summary
MBX Biosciences Inc
According to Wall Street analysts, the average 1-year price target for MBX is 38.15 USD with a low forecast of 30.3 USD and a high forecast of 46.2 USD.
Dividends
Current shareholder yield for MBX is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one MBX stock under the Base Case scenario is 7.84 USD.
Compared to the current market price of 12.47 USD, MBX Biosciences Inc is Overvalued by 37%.